SCHEMBL373261

SCHEMBL373261

C=CC(=O)OCC(C)N(C)C

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.64
HPGD P15428 1/20 0.42
ALDH1A1 P00352 4/20 0.42
TP53 P04637 3/20 0.42
HIF1A Q16665 3/20 0.42
CYP3A4 P08684 2/20 0.42
HSD17B10 Q99714 1/20 0.42
CHRNB2 P17787 8/20 0.40
CHRNA4 P43681 8/20 0.40
CHRNB4 P30926 6/20 0.40
CHRNA3 P32297 6/20 0.40
ACHE P22303 1/20 0.39
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7722236 0.98 TSHR (0.62) TSHRHPGDALDH1A1TP53HIF1A
Chloromethane SCHEMBL27908728 0.96 TSHR (0.60) TSHRHPGDALDH1A1TP53HIF1A
Acrylic Acid SCHEMBL22129824 0.94 TSHR (0.58) TSHRHPGDALDH1A1TP53HIF1A
Methacrylic Acid SCHEMBL27792060 0.90 TSHR (0.53) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL3404229 0.84 TSHR (0.55) TSHRHPGDALDH1A1TP53HIF1A
SCHEMBL5013889 0.83 CHRNB2 (0.47) TSHRCHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL4419961 0.83 CHRNB2 (0.47) TSHRCHRNB2CHRNA4CHRNB4CHRNA3
SCHEMBL11237665 0.83 CHRNB2 (0.47) TSHRCHRNB2CHRNA4CHRNB4CHRNA3
Styrene SCHEMBL28750973 0.83 TSHR (0.46) TSHRALDH1A1CHRNB2CHRNA4CHRNB4
SCHEMBL28454119 0.82 TSHR (0.61) TSHRHPGDALDH1A1TP53HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220233747-A1 TWO-COMPONENT SYSTEM FOR THE IN SITU PREPARATION OF AN ARTIFICIAL CARTILAGE HERAEUS MEDICAL GMBH (DE) 2022-07-28 US claimed
EP-3997140-A1 TWO-COMPONENT SYSTEM FOR THE IN SITU PREPARATION OF AN ARTIFICIAL CARTILAGE Heraeus Medical GmbH (DE) 2022-05-18 EP claimed
WO-2021004688-A1 TWO-COMPONENT SYSTEM FOR THE IN SITU PREPARATION OF AN ARTIFICIAL CARTILAGE HERAEUS MEDICAL GMBH (DE) 2021-01-14 WO claimed
EP-3763754-A1 TWO-COMPONENT SYSTEM FOR THE IN SITU PREPARATION OF AN ARTIFICIAL CARTILAGE Heraeus Medical GmbH (DE) 2021-01-13 EP claimed
US-20170320992-A1 POLY(ALKYLENE CARBONATE)-BASED AMPHIPHILIC BLOCK COPOLYMERS AND METHODS OF USE THEREOF PURDUE RESEARCH FOUNDATION (US) 2017-11-09 US claimed
WO-2016077614-A1 POLY(ALKYLENE CARBONATE)-BASED AMPHIPHILIC BLOCK COPOLYMERS AND METHODS OF USE THEREOF PURDUE RESEARCH FOUNDATION (US) 2016-05-19 WO claimed
CN-103492496-A Blend composition, flexible pipe material and method for manufacturing blend SAINT GOBAIN PERFORMANCE PLAST 2014-01-01 CN claimed
US-6576255-B1 Injection molding method for (meth)acrylate copolymers having tertiary ammonium groups ROEHM GMBH & CO. KG (DE) 2003-06-10 US claimed
US-20260118253-A1 CYTOMETRIC CONTROL, REFERENCE, AND CALIBRATION USING HYDROGEL PARTICLES SLINGSHOT BIOSCIENCES INC (US) 2026-04-30 US disclosed
EP-4731188-A2 SYNTHETIC CELLS COMPRISING TNF-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) AND METHODS OF USING THE SAME Slingshot Biosciences, Inc. (US) 2026-04-29 EP disclosed
US-20260061069-A1 SIZE-TUNABLE SYNTHETIC PARTICLES FOR IMMUNE CELL ACTIVATION SLINGSHOT BIOSCIENCES INC (US) 2026-03-05 US disclosed
EP-4695598-A2 CYTOMETRIC CONTROL, REFERENCE, AND CALIBRATION USING HYDROGEL PARTICLES Slingshot Biosciences, Inc. (US) 2026-02-18 EP disclosed
US-12534480-B2 Organic compounds and applications thereof in optoelectronic field ZHEJIANG BRILLIANT OPTOELECTRONIC TECHNOLOGY CO., LTD. (CN) 2026-01-27 US disclosed
US-20260016390-A1 COMPOSITIONS AND METHODS FOR CELL-LIKE CALIBRATION PARTICLES SLINGSHOT BIOSCIENCES, INC. (US) 2026-01-15 US disclosed
EP-0326516-A2 Method of making patterns CIBA-GEIGY AG (CH) 1989-08-02 EP disclosed
US-4773913-A Acrylate resins as binders for color concentrates ROHM GMBH (DE) 1988-09-27 US disclosed
US-4705695-A AMMONIUM SALT OF TERTIARY AMINE SUBSTITUTED ACRYLIC POLYMER ROHM GMBH CHEMISCHE FABRIK (DE) 1987-11-10 US disclosed
US-4367745-A Conformable electrically conductive compositions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1983-01-11 US disclosed
US-4273135-A IMPROVED ELECTROCONDUCTIVE INTERFACE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1981-06-16 US disclosed
US-3976824-A Treating agent useful for fibrous materials and preparation thereof ARAKAWA RINSAN KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1976-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170320992-A1 POLY(ALKYLENE CARBONATE)-BASED AMPHIPHILIC BLOCK COPOLYMERS AND METHODS OF USE THEREOF PARG, PICALM, PHOSPHO1 TSHR 4590/4885HPGD 4027/4885ALDH1A1 4855/4885
US-12534480-B2 Organic compounds and applications thereof in optoelectronic field OR10J3, CCR9, NAF1 TSHR 1758/4885HPGD 3860/4885ALDH1A1 282/4885
US-20260061069-A1 SIZE-TUNABLE SYNTHETIC PARTICLES FOR IMMUNE CELL ACTIVATION ICOS, CD47, CD4 TSHR 129/4885HPGD 3712/4885ALDH1A1 4461/4885
US-20260118253-A1 CYTOMETRIC CONTROL, REFERENCE, AND CALIBRATION USING HYDROGEL PARTICLES RAD1, CD44, CD47 TSHR 1477/4885HPGD 3862/4885ALDH1A1 582/4885
US-20260016390-A1 COMPOSITIONS AND METHODS FOR CELL-LIKE CALIBRATION PARTICLES CD44, CD63, ACTB TSHR 2848/4885HPGD 1951/4885ALDH1A1 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.